Search

Your search keyword '"TUBERCULOSIS vaccines"' showing total 6,679 results

Search Constraints

Start Over You searched for: Descriptor "TUBERCULOSIS vaccines" Remove constraint Descriptor: "TUBERCULOSIS vaccines"
6,679 results on '"TUBERCULOSIS vaccines"'

Search Results

1. DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies.

2. Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans.

3. Immunogenicity and Protective Efficacy of a Multi-Antigen Mycobacterium tuberculosis Subunit Vaccine in Mice.

4. Marine sponge microbe provides insights into evolution and virulence of the tubercle bacillus.

5. “We’re Not Lab Rats”: Analysis of Netizens’ Response to BCG Vaccine-Test Proposal Against COVID-19 in Africa.

6. A noninvasive BCG skin challenge model for assessing tuberculosis vaccine efficacy.

7. Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report.

8. From pathogenesis to antigens: the key to shaping the future of TB vaccines.

9. Regional disparities in BCG vaccination coverage and tuberculosis incidence in infants among Brazilian states.

10. Trends in Viral Vector-Based Vaccines for Tuberculosis: A Patent Review (2010–2023).

11. Optimal control of tuberculosis disease spread with imperfect vaccination.

13. Modeling the Dynamics of Tuberculosis with Vaccination, Treatment, and Environmental Impact: Fractional Order Modeling.

14. The seroconversion history to SARS-CoV-2 in Indigenous people from Brazil - the interplay between exposure, vaccination, and tuberculosis.

15. Estimating the Potential Public Health Value of BCG Revaccination.

16. Mathematical analysis of a novel fractional order vaccination model for Tuberculosis incorporating susceptible class with underlying ailment.

17. Boosting Immunogenicity of a Recombinant Mycobacterium smegmatis Strain via Zinc-Dependent Ribosomal Proteins.

18. Mycobacterium tuberculosis –Human Immunodeficiency Virus Infection and the Role of T Cells in Protection.

19. Mathematical modeling of two strains tuberculosis and COVID-19 vaccination model: a co-infection study with cost-effectiveness analysis.

20. Medical Students’ Clinical Knowledge of Integrated Management of Childhood Illness A cross-sectional comparative study.

21. BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.

22. Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria.

23. Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity.

24. Tuberculosis Vaccines and T Cell Immune Memory.

25. Susceptibility testing of the live attenuated tuberculosis vaccine BCG and the vaccine candidate MTBVAC to currently WHO-recommended anti-tuberculosis drugs by the European committee on antimicrobial susceptibility testing (EUCAST) method.

26. Finding antigens for TB vaccines: the good, the bad and the useless

27. Recombinant mycobacterial DNA-binding protein 1 with post-translational modifications boosts IFN-gamma production from BCG-vaccinated individuals' blood cells in combination with CpG-DNA.

28. Non-specific effects of inactivated Mycobacterium bovis oral and parenteral treatment in a rabbit scabies model.

29. Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice.

30. Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development.

31. Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial.

32. Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: Estimates for South Africa.

33. Lung IL-17A-Producing CD4 + T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines.

34. Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice

36. MICHIGAN TESTING ORAL TUBERCULOSIS VACCINE ON FREE-RANGING WHITETAILS.

37. Effect of glycosylation on the affinity of the MTB protein Ag85B for specific antibodies: towards the design of a dual-acting vaccine against tuberculosis.

38. Fractional-Order Model for Evolution of Bovine Tuberculosis with Vaccination and Contaminated Environment.

39. Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis.

40. Assessing the Genetic Diversity of Mycobacterium tuberculosis Strains in Kerala, India: A Comprehensive Study.

41. Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies.

42. Mathematical Modeling and Sensitivity Analysis of COVID-19 and Tuberculosis Coinfection with Vaccination.

43. Safety and Immunogenicity of an In Vivo Muscle Electroporation Delivery System for DNA- hsp65 Tuberculosis Vaccine in Cynomolgus Monkeys.

44. Comparison of the Immunogenicity and Efficacy of rBCG-EPCP009, BCG Prime-EPCP009 Booster, and EPCP009 Protein Regimens as Tuberculosis Vaccine Candidates.

45. Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model.

46. Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine development.

47. Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates.

48. An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials.

49. Lung type 3 innate lymphoid cells respond early following Mycobacterium tuberculosis infection

50. Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17–Dependent Protection against Mycobacterium tuberculosis Infection

Catalog

Books, media, physical & digital resources